Home Gut and Digestive Health Fecal Calprotectin Test: IBS vs IBD, Cutoffs, and Next Steps

Gut and Digestive Health

Fecal Calprotectin Test: IBS vs IBD, Cutoffs, and Next Steps

March 6, 2026 Modified date: March 6, 2026

A fecal calprotectin test is a practical way to answer a common, stressful question: are your symptoms more likely to come from irritation and sensitivity (as in IBS) or from true intestinal inflammation (as in IBD)? Calprotectin is a protein released mainly by neutrophils—immune cells that surge into the gut when the lining is inflamed. Because it is measured in stool, it reflects what is happening in the intestine more directly than many blood tests. Used well, it can reduce unnecessary colonoscopies, flag when symptoms deserve faster investigation, and help monitor inflammation over time in people already diagnosed with IBD. The key is interpretation: the number is meaningful, but it is not a diagnosis by itself. Knowing typical cutoffs, common “false alarms,” and the right next step can turn a confusing lab result into a clear plan.

Quick Overview

A low calprotectin result makes active intestinal inflammation less likely and often supports an IBS-focused approach when red flags are absent.
Borderline results are common and often call for a repeat test after addressing short-term triggers like infections or certain medications.
A clearly elevated result suggests intestinal inflammation and usually warrants further evaluation rather than symptom-only treatment.
Avoid starting or stopping prescription medicines based solely on one result; interpret the number with symptoms, history, and timing.

What the fecal calprotectin test shows
Getting an accurate sample
Common calprotectin cutoffs and gray zones
IBS and IBD how doctors use the number
Causes of high calprotectin besides IBD
Next steps after a low or high result
Using calprotectin to track IBD

What the fecal calprotectin test shows

Fecal calprotectin is best thought of as an “inflammation signal” coming from the intestinal lining. When the gut wall is irritated by inflammation, neutrophils migrate into the tissue and release calprotectin. The more neutrophil-driven inflammation in the intestine, the higher the stool calprotectin tends to be.

What it helps you answer

For people with ongoing digestive symptoms—especially diarrhea, urgency, mucus, or abdominal pain—the test is commonly used to help sort two broad buckets:

Inflammatory patterns, where the intestine itself is inflamed (for example, Crohn’s disease or ulcerative colitis).
Non-inflammatory patterns, where symptoms can be intense but the lining is not inflamed (often consistent with IBS and other functional gut disorders).

A major benefit is that it can support a “positive” approach to care: instead of treating IBS as a diagnosis of exclusion that requires endless testing, a low calprotectin result can make active inflammation less likely and help move forward with symptom-directed management when the overall picture fits.

What it cannot do

Calprotectin does not tell you the exact cause of inflammation. A high result can occur with IBD, but also with infections, medication-related irritation, and other inflammatory conditions. It also does not reliably pinpoint where inflammation is (colon vs small bowel), and it can miss some limited or patchy disease.

How it differs from blood markers

Blood tests like CRP can reflect inflammation anywhere in the body, and some people with active IBD have normal CRP. Stool calprotectin is more gut-centered. That is why it is often used as a first step when the question is specifically about intestinal inflammation.

The bottom line: calprotectin is a strong triage tool and a useful trend tool, but it is not a stand-alone diagnosis.

Getting an accurate sample

Because calprotectin can shift with short-term changes in the gut, how and when you test matters. A “clean” sample and sensible timing reduce the chance of a misleading result and help your clinician trust the number.

Practical collection tips that matter

Most kits use a small sampling device that transfers stool into a tube. The usual goals are consistency and avoiding contamination:

Collect from stool that has not mixed with toilet water.
Avoid urine contamination.
If you have diarrhea, follow kit instructions carefully (watery stools are still testable, but sampling needs care).
Label and deliver promptly according to the kit’s storage directions.

If you are menstruating, consider postponing until bleeding has stopped to reduce confusion from accidental blood contamination in the sample.

Timing: when a repeat is smarter than a rush

Calprotectin can rise for a short period after a viral or bacterial gastroenteritis. If you had a recent “stomach bug,” travel-related diarrhea, or sudden onset symptoms with fever, it may be wiser to test after you have been stable for a couple of weeks—unless your symptoms are severe, persistent, or accompanied by red flags.

Medications and exposures to discuss before testing

Some common medicines can irritate the gut lining or shift results. Do not stop prescribed medications on your own, but it is worth asking whether timing adjustments are appropriate:

NSAIDs (such as ibuprofen or naproxen) can raise calprotectin in some people; many clinicians prefer a washout period of about 1 to 2 weeks if clinically safe.
Proton pump inhibitors may be associated with modest elevations in some settings.
Recent antibiotics can change gut flora and sometimes coincide with infectious diarrhea or inflammation.

Also mention recent heavy alcohol intake, intense endurance exercise, and any new supplements that have upset your stomach. These do not explain most high results, but they can add noise when a number is borderline.

An accurate sample does not guarantee a perfect interpretation, but it prevents avoidable confusion—especially in the gray zone where repeat testing is often the best next step.

Common calprotectin cutoffs and gray zones

One of the most frustrating parts of calprotectin testing is that “normal” is not a single universal number. Different labs and assays can use slightly different reference ranges, and age and clinical context matter. Still, there are widely used practical bands that help guide next steps.

A useful way to think in ranges

Many clinicians interpret adult results using bands like these (always confirm your lab’s reference interval):

Under 50 µg/g: Often considered low and less consistent with active IBD.
About 50 to 150 µg/g: A borderline zone where mild inflammation, recent infection, medication effects, or early IBD can overlap.
Over 150 µg/g: More suggestive of intestinal inflammation that deserves evaluation, especially if symptoms fit.
Over 250 to 300 µg/g: Often treated as a “high probability” zone for clinically significant inflammation, although it is still not specific to IBD.

These are not magic thresholds. They are decision aids: the higher the number, the more the conversation shifts from “symptom management first” toward “find the inflammatory cause.”

Why borderline results are so common

Borderline results happen because calprotectin is sensitive. Mild inflammation from a temporary infection, a flare of diverticulitis, or NSAID irritation can push the number into the gray zone. Day-to-day variability can also matter; a single borderline value is often less informative than a repeat that stays elevated or climbs.

A common approach is to repeat a borderline test in about 2 to 4 weeks, ideally after addressing obvious short-term triggers (finishing an infection workup, limiting NSAIDs if appropriate, stabilizing diet and bowel pattern). A stable low repeat supports a non-inflammatory pattern; a rising repeat strengthens the case for further investigation.

Special situations that shift interpretation

Children: Baseline calprotectin can be higher in young children, especially infants, so pediatric cutoffs and context are essential.
Older adults: The tolerance for “watch and wait” is lower if there is new anemia, weight loss, or bleeding; evaluation may proceed regardless of the exact number.
Known IBD: Targets are often lower than “rule-out” cutoffs. In monitoring, a change from your personal baseline can matter even if the value is not extremely high.

If you remember only one thing: treat calprotectin as a probability tool, not a verdict—especially in the middle range.

IBS and IBD how doctors use the number

IBS and IBD can overlap in symptoms, but they differ in what is happening in the gut wall. IBS is a disorder of gut-brain signaling, motility, and sensitivity; symptoms can be severe, yet standard tests show no mucosal inflammation. IBD is defined by inflammation that can damage the intestinal lining. Calprotectin is useful because it tracks that inflammatory biology.

When a low result supports an IBS pathway

If calprotectin is low and there are no alarm features, clinicians often feel more confident focusing on IBS-style management rather than escalating to invasive testing. In practical terms, that might include:

Diet strategies (often a structured trial of low FODMAP with reintroduction rather than permanent restriction)
Soluble fiber for constipation-predominant symptoms
Antidiarrheal options when appropriate
Peppermint oil or antispasmodics for cramping
Stress and sleep interventions that reduce gut sensitivity over time

A low result does not mean symptoms are “in your head.” It means the symptom driver is less likely to be neutrophil-driven inflammation, which helps narrow the plan.

When the number cannot overrule the story

Even with a low calprotectin result, clinicians look for reasons to investigate further. Examples include:

Persistent or recurrent rectal bleeding
Iron-deficiency anemia
Unexplained weight loss
Nocturnal diarrhea that wakes you from sleep
A strong family history of IBD or colorectal cancer
New symptoms after age 50

In these cases, further evaluation may be appropriate even if calprotectin is low, because some important conditions are not reliably excluded by a single biomarker.

How symptoms and the number combine

A helpful way to picture decision-making is as a grid:

Mild symptoms + low calprotectin: IBS-oriented care is often reasonable.
Severe symptoms + low calprotectin: consider alternate diagnoses (bile acid diarrhea, celiac disease, microscopic colitis, medication effects) and escalate based on red flags.
Mild symptoms + elevated calprotectin: repeat testing and trigger review may be appropriate before invasive steps.
Moderate to severe symptoms + clearly elevated calprotectin: inflammatory evaluation becomes a priority.

This combined approach is why two people with the same number can have different next steps.

Causes of high calprotectin besides IBD

A high calprotectin level points toward intestinal inflammation, but IBD is only one category on the list. Knowing common alternatives prevents premature conclusions and can guide the right confirmatory testing.

Short-term and reversible causes

These are common reasons calprotectin rises and then falls:

Infectious gastroenteritis (bacterial infections in particular can cause marked elevations)
Recent antibiotic-associated diarrhea, including inflammatory forms
Diverticulitis
Recent bowel preparation or a recent colonoscopy (timing can matter)
Medication-related irritation, especially NSAIDs in susceptible people

If symptoms began abruptly with fever, travel exposure, or household illness, stool pathogen testing may be appropriate alongside—or even before—repeating calprotectin.

Conditions that can mimic IBD signals

Several disorders can produce inflammation and an elevated calprotectin without being classic Crohn’s disease or ulcerative colitis:

Microscopic colitis (often presents with chronic watery diarrhea; calprotectin may be normal or mildly elevated, so interpretation is nuanced)
Celiac disease (usually evaluated with blood testing, but intestinal inflammation can influence markers)
Colorectal polyps or colorectal cancer, particularly when bleeding or anemia is present
Inflammatory changes from radiation or ischemia in specific contexts

This is why a high calprotectin result often triggers a broader evaluation rather than an automatic IBD label.

Location matters: why some IBD can look “less elevated”

Calprotectin tends to reflect colonic inflammation strongly. Inflammation limited to the small bowel can be harder to detect, and mild disease can produce only modest elevations. Conversely, severe colonic inflammation can drive very high results.

Think in patterns, not single points

A one-time elevation should be interpreted with timing and triggers. Persistent elevation, rising values, or elevation plus classic inflammatory symptoms (bloody diarrhea, urgency, nocturnal symptoms, weight loss) makes an inflammatory workup more urgent. A single spike that normalizes after an infection is a different story.

In other words, calprotectin is excellent at saying “inflammation is likely,” but it needs follow-through to answer “which inflammation, where, and why.”

Next steps after a low or high result

Once you have a result, the most useful question is not “What do I have?” but “What is the safest next step?” The plan depends on the value range, how long symptoms have lasted, and whether alarm features are present.

If calprotectin is low

When symptoms fit IBS and there are no red flags, next steps often focus on symptom control and identifying common non-inflammatory drivers:

Clarify the symptom pattern (diarrhea-predominant, constipation-predominant, mixed, or bloating-predominant).
Check targeted basics when appropriate (for example, celiac screening in chronic diarrhea, thyroid testing when constipation is prominent, and medication review).
Start one structured intervention at a time so you can tell what helps:

A 2 to 6 week guided low FODMAP trial with reintroduction
Soluble fiber titrated slowly for constipation or mixed symptoms
Lactose reduction trial if dairy consistently triggers symptoms
Stress and sleep support (often underestimated for gut sensitivity)

If symptoms remain severe despite low calprotectin, clinicians may look beyond IBS, including bile acid diarrhea, pelvic floor dysfunction, small intestinal bacterial overgrowth in select cases, or microscopic colitis depending on age and stool pattern.

If calprotectin is borderline

A common pathway is: address triggers and repeat.

Review recent infections, NSAID use, and new medications.
Consider stool testing for pathogens if diarrhea is prominent or exposure risk is high.
Repeat calprotectin in about 2 to 4 weeks if symptoms are stable and there are no alarm features.

A falling or normalized repeat supports a non-inflammatory direction. A persistent or rising repeat usually shifts toward endoscopic evaluation or gastroenterology referral.

If calprotectin is clearly elevated

At higher levels—especially when symptoms suggest inflammation—next steps often include:

Basic bloodwork (complete blood count, iron studies if anemia is suspected, inflammatory markers)
Stool testing to rule out infection when relevant
Gastroenterology evaluation, often with colonoscopy and biopsies
Imaging when small bowel Crohn’s disease is a concern

If you have severe symptoms (dehydration, frequent bloody stools, fever, severe abdominal pain), escalation should be prompt rather than “repeat later.”

The best use of calprotectin is pairing the number with a deliberate next step—either focused symptom care when low, or inflammation-focused evaluation when high.

Using calprotectin to track IBD

For people already diagnosed with IBD, calprotectin often shifts from a “Do I have inflammation?” test to a “How active is inflammation right now?” tool. This matters because symptoms can lag behind inflammation—or persist even after inflammation improves.

Why monitoring can change outcomes

Inflammation that smolders without obvious symptoms can still increase the risk of flares, steroid use, hospitalization, and long-term complications. A stool biomarker offers a noninvasive way to detect trouble earlier than waiting for a major flare.

Clinicians often use calprotectin to:

Check whether a treatment is controlling inflammation (especially after starting or changing therapy)
Estimate the likelihood of mucosal healing when symptoms are improved
Identify relapse risk when a previously stable pattern starts rising
Decide whether symptoms are more likely inflammatory or functional in someone with known IBD

Targets are individualized, but trends are powerful

In monitoring, many clinicians aim for values in a lower range than “diagnostic rule-out” cutoffs. The specific target varies by disease type, disease location, and the overall plan (for example, treat-to-target strategies). Even more important is direction:

A steady decline after treatment changes suggests improving control.
A sustained rise across repeated tests increases concern for recurrence or ongoing activity.
A mismatch—worsening symptoms with stable low calprotectin—can point toward non-inflammatory drivers (diet triggers, bile acid issues, infections, strictures, pelvic floor dysfunction) that require a different solution.

How often is it checked

There is no single schedule for everyone, but a common pattern is more frequent testing during active adjustment and less frequent testing in stable remission. Many clinicians recheck within a few months after a meaningful treatment change, and then space out testing when results and symptoms are consistently stable.

Limitations to keep in mind

Calprotectin may be less sensitive for isolated small bowel disease, and values can be influenced by infections or medications. That is why clinicians interpret it alongside clinical symptoms, imaging, and endoscopy history rather than treating it as a stand-alone “flare detector.”

Used thoughtfully, calprotectin can serve as a practical early-warning system—especially when you and your care team pay attention to trends, not just single readings.

References

Disclaimer

This article is for educational purposes and does not provide medical advice, diagnosis, or treatment. Fecal calprotectin results should be interpreted by a qualified clinician who can consider your symptoms, medical history, medications, and risk factors. Seek urgent medical care if you have severe or worsening abdominal pain, dehydration, fainting, black or bloody stools, persistent fever, or signs of significant weakness or anemia.

If you found this guide helpful, please consider sharing it on Facebook, X (formerly Twitter), or any platform you prefer so others can benefit from clear, evidence-informed digestive health information.